valve-rel complic hancock bioprosthesi twelve- fourteen-year follow-up studi valve-rel morbid mortal heart replac hancock bioprosthesi june decemb hancock mitral aortic select patient oper follow-up june follow-up year accumul follow-up patient-year seventeen patient mitral replac aortic valv replac mitral aortic valv replac thromboembol event probabl free thromboembol year mitral valv replac group aortic group mitral-aort group fifteen episod prosthet valv endocard instanc nonstructur dysfunct paravalvular leak mitral valv aortic valv twenty-two bioprosthes patient structur deterior probabl freedom structur deterior year mitral group aortic group mitral-aort group logist regress analysi age time oper bioprosthet life structur deterioration-fre period linear regress curv late death patient reoper actuari surviv rate hospit mortal year entir seri signific differ group probabl free valve-rel morbid mortal year mitral group aortic group mitral-aort group long-term result seri show clinic perform hancock valv satisfactori first year behavior bioprosthesi year follow-up chang minor group patient free valve-rel complic restrict use patient 